Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE: 300573)

Shenyang Xingqi Pharmaceutical Co.,Ltd. Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	390.97	480.42	515.45	686.36	37.22	49.96
Cash & Short-Term Investments	390.97	480.42	515.45	686.36	37.22	49.96
Cash Growth	-9.69%	-6.80%	-24.90%	1744.12%	-25.51%	76.10%
Accounts Receivable	311.13	252.1	194.96	170.62	158.23	130.39
Other Receivables	4.56	3.93	4.62	5.84	3.15	1.91
Receivables	315.69	256.03	199.58	176.46	161.37	132.3
Inventory	149.37	136.03	122.27	92.33	68.31	79.87
Other Current Assets	36.97	32.71	27.87	29.27	27.32	19.64
Total Current Assets	893	905.19	865.17	984.42	294.22	281.78
Property, Plant & Equipment	862.76	837.35	695.92	548.6	527.9	474.25
Long-Term Investments	10	-	-	-	-	2.2
Other Intangible Assets	139.36	78.29	27.66	22.83	23.83	23.84
Long-Term Deferred Tax Assets	50.78	38.57	23.77	30.45	33.87	13.28
Long-Term Deferred Charges	65.82	118.76	105.03	60.77	28.22	9.02
Other Long-Term Assets	60.98	45.68	65.39	39.78	57.67	48
Total Assets	2,083	2,024	1,783	1,687	965.7	852.37
Accounts Payable	17.32	17.57	19.46	13.31	6.67	26.52
Accrued Expenses	168.49	125.36	103.97	108.91	91.74	67.13
Short-Term Debt	250.69	70.06	-	100	80	90
Current Portion of Leases	7.98	6.87	7.12	4.18	-	-
Current Income Taxes Payable	26.98	5.74	-	11.69	-	8.77
Current Unearned Revenue	3.68	6.55	2.01	6.11	5.11	-
Other Current Liabilities	33.01	27.98	19.89	22.63	28.98	28.65
Total Current Liabilities	508.16	260.12	152.45	266.83	212.49	221.07
Long-Term Leases	2.18	2.22	6.69	7.1	-	-
Long-Term Unearned Revenue	68.29	71.58	71.5	68.42	59.15	56.4
Total Liabilities	578.62	333.92	230.63	342.35	271.64	277.46
Common Stock	174.42	124.59	88.56	88.1	82.37	82.43
Additional Paid-In Capital	859.78	891.01	852.36	782.68	288.16	256.23
Retained Earnings	469.88	674.32	611.4	479	327.11	249.41
Treasury Stock	-	-	-	-5.28	-13.26	-19.56
Comprensive Income & Other	-	-	-	-	-2.2	-
Total Common Equity	1,504	1,690	1,552	1,344	682.19	568.51
Minority Interest	-	-	-	-	11.87	6.39
Shareholders' Equity	1,504	1,690	1,552	1,344	694.06	574.9
Total Liabilities & Equity	2,083	2,024	1,783	1,687	965.7	852.37
Total Debt	260.85	79.15	13.81	111.28	80	90
Net Cash (Debt)	130.12	401.27	501.64	575.08	-42.78	-40.04
Net Cash Growth	-64.91%	-20.01%	-12.77%	-	-	-
Net Cash Per Share	0.74	2.30	2.91	3.59	-0.27	-0.26
Filing Date Shares Outstanding	174.42	174.42	173.57	172.67	161.44	145.76
Total Common Shares Outstanding	174.42	174.42	173.57	172.67	161.44	145.76
Working Capital	384.84	645.07	712.72	717.59	81.72	60.71
Book Value Per Share	8.62	9.69	8.94	7.79	4.23	3.90
Tangible Book Value	1,365	1,612	1,525	1,322	658.36	544.67
Tangible Book Value Per Share	7.82	9.24	8.78	7.65	4.08	3.74
Buildings	496.27	476.93	470.69	350.19	347.48	343.48
Machinery	783.53	711.75	534.35	481.36	438.86	318.61
Construction In Progress	82.94	106.16	70.12	34.94	22.31	51.88

Source: S&P Capital IQ. Standard template. Financial Sources.